M. Jamil is a results-oriented pharmaceutical leader with two decades of strategic and operational experience in complex, cross-geo operations of matrix organizations. Jamil is passionate about leading high-functioning team and using technology (biology & digital) to improve and extend lives of cancer patients. Jamil is currently working at Merck & Co to help commercialize an immunotherapy product. Previously he had worked in marketing and commercial roles of increasing responsibility at Bayer, Eli Lilly and Novartis in US, Switzerland, Israel, Saudi Arabia and Emerging Markets to launch multiple products in numerous therapeutic areas. Jamil got his Ph.D. in Marketing from Kelley School of Business, Indiana University. He has several publications in leading journals and is currently an adjunct faculty at Columbia Business School.